Sign in / Join Now
ETFs & Funds
Ugly. Two stocks I like for changing demographics but seems no one else does. No position.....yet.
MAKO to volatile and if I am correct they have no money. I would also like to see more data and some kind of outlook.
Add a reply...
Latest StockTalks »
people get ABMD breaking news and analysis by email alert.
Get email alerts on ABMD »
Get latest price
From other sites
Abiomed Announces Preliminary Q3 FY 2017 Revenue Of $114.7 Million, Up 34% Over Prior Year
at TheStreet (Jan 9, 2017)
Abiomed Third Quarter Fiscal 2017 Earnings And Conference Call Notification
at TheStreet (Jan 5, 2017)
Abiomed To Present At The 35th Annual J.P. Morgan Healthcare Conference
at TheStreet (Dec 27, 2016)
Interesting ABMD Put And Call Options For February 2017
at Nasdaq.com (Dec 21, 2016)
ABIOMED Impella CP Gets Expanded FDA Approval, Stock Up
at Zacks.com (Dec 8, 2016)